Literature DB >> 7246555

Estimating creatinine clearance in morbidity obese patients.

R E Dionne, L A Bauer, G A Gibson, W O Griffen, R A Blouin.   

Abstract

Estimates of creatinine clearance (Clcr), using five methods, were compared to measured Clcr in morbidity obese patients. Patients whose total body weight (TBW) was greater than or equal to 195% of their ideal body weight (IBW) and who had urinary Clcr measured with 24-hour urine collections were studied. The 12 men weighed an average of 180 kg; the 31 women averaged 138 kg. The methods studied considered a combination of the following factors: weight, age, sex, and serum creatinine. One method was a nomogram; TBW could not be used because of limitations of the nomogram. Both TBW and IBW were used in two methods that considered weight as a variable. Measured Clcr averaged 105.7 ml/min/1.73 sq m body surface area. All estimating methods using IBW significantly underestimated Clcr; all methods using TBW significantly overestimated Clcr. Two methods that did not include body weight as a variable predicted Clcr more accurately than did other methods, but there was still a significant difference between estimated and measured Clcr. None of the Clcr estimation methods is accurate in morbidly obese patients.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7246555

Source DB:  PubMed          Journal:  Am J Hosp Pharm        ISSN: 0002-9289


  19 in total

1.  Measurement of glomerular filtration rate in obese patients: pitfalls and potential consequences on drug therapy.

Authors:  Grégoire Wuerzner; Murielle Bochud; Vittorio Giusti; Michel Burnier
Journal:  Obes Facts       Date:  2011-06-06       Impact factor: 3.942

2.  Rapid estimation of creatinine clearances in patients with liver dysfunction.

Authors:  N P Lam; R Sperelakis; J Kuk; J D Seeger; A H Lau
Journal:  Dig Dis Sci       Date:  1999-06       Impact factor: 3.199

3.  Effect of body weight on the pharmacokinetics of cyclophosphamide in breast cancer patients.

Authors:  G Powis; P Reece; D L Ahmann; J N Ingle
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

Review 4.  Kidney Function in Obesity-Challenges in Indexing and Estimation.

Authors:  Alex R Chang; Waleed Zafar; Morgan E Grams
Journal:  Adv Chronic Kidney Dis       Date:  2018-01       Impact factor: 3.620

Review 5.  Clinical pharmacokinetics and endocrine disorders. Therapeutic implications.

Authors:  P O'Connor; J Feely
Journal:  Clin Pharmacokinet       Date:  1987-12       Impact factor: 6.447

Review 6.  Drug disposition in obese humans. An update.

Authors:  D R Abernethy; D J Greenblatt
Journal:  Clin Pharmacokinet       Date:  1986 May-Jun       Impact factor: 6.447

7.  Influence of weight on aminoglycoside pharmacokinetics in normal weight and morbidly obese patients.

Authors:  L A Bauer; W A Edwards; E P Dellinger; D A Simonowitz
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

8.  Patient-controlled analgesia: a new concept of postoperative pain relief.

Authors:  R L Bennett; R L Batenhorst; B A Bivins; R M Bell; D A Graves; T S Foster; B D Wright; W O Griffen
Journal:  Ann Surg       Date:  1982-06       Impact factor: 12.969

9.  Vancomycin pharmacokinetics in normal and morbidly obese subjects.

Authors:  R A Blouin; L A Bauer; D D Miller; K E Record; W O Griffen
Journal:  Antimicrob Agents Chemother       Date:  1982-04       Impact factor: 5.191

10.  The relationship between simple renal cysts and glomerular filtration rate in the elderly.

Authors:  Ali Abbas Ozdemir; Korhan Kapucu
Journal:  Int Urol Nephrol       Date:  2016-09-09       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.